Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis.
Michal SternschussRinat YerushalmiRamy R SalehEitan AmirHadar GoldvaserPublished in: Journal of cancer research and clinical oncology (2021)
Combination of ICIs and NACT were associated with improved outcome in early-stage TNBC while increasing toxicity significantly. Longer follow-up is desired to better understand the risk and benefit ratio of this combination.